These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27435958)

  • 1. Patient acceptance of the Heart-to-Heart program: Using patients' native hearts to promote post-transplant health.
    Reynolds MC; Carey SA; Driver S; Ko J; Felius J; Roberts WC; Hall SA
    J Heart Lung Transplant; 2016 Oct; 35(10):1270-1271. PubMed ID: 27435958
    [No Abstract]   [Full Text] [Related]  

  • 2. Setting the stage for development of a program for adolescent heart transplant recipients to transition to adult providers: An integrative review of the literature.
    Hallowell SC
    J Spec Pediatr Nurs; 2014 Oct; 19(4):285-95. PubMed ID: 25131637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning to Live Again: The Role of Education in Heart Transplant Recipients.
    Mohney K
    Crit Care Nurs Q; 2018; 41(4):389-393. PubMed ID: 30153182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring parenthood in the New Zealand Heart Transplant Program.
    Wasywich CA; Ruygrok AM; Gibbs H; Painter L; Coverdale HA; Ruygrok PN
    Transplant Proc; 2013; 45(6):2414-8. PubMed ID: 23747185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Face-to-face Sun Protection Training and Text Messages Improve Sun Protection Behaviour in Adolescent Organ Transplant Recipients: HIPPOlino Feasibility Study.
    Sachse MM; Böttcher S; Pape L; Wagner G; Mehls O; Klaus G; Laschewski G; Barz M; Jahn I; Zeeb H
    Acta Derm Venereol; 2016 Mar; 96(3):341-5. PubMed ID: 26336924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficult conversations: Australian Indigenous patients' views on kidney transplantation.
    Devitt J; Anderson K; Cunningham J; Preece C; Snelling P; Cass A
    BMC Nephrol; 2017 Oct; 18(1):310. PubMed ID: 29020932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of Massive Cardiac Adiposity (Floating Heart) in the Native Hearts of Patients Having Heart Transplantation at a Single Texas Hospital (2013 to 2015) and Comparison of Various Clinical and Morphologic Variables in the Patients With Massive Versus Nonmassive Cardiac Adiposity.
    Roberts WC; Won VS; Vasudevan A; Ko JM; Hall SA; Gonzalez-Stawinski GV
    Am J Cardiol; 2016 Apr; 117(8):1375-80. PubMed ID: 26912162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pre-transplant evaluation: which patients for the active list?].
    Soares RM
    Rev Port Cardiol; 2001 Mar; 20 Suppl 3():59-65. PubMed ID: 11409075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the internet by United States heart transplant centers to promote transparency in the process of patient selection.
    Bramstedt KA; Young JB
    Telemed J E Health; 2006 Jun; 12(3):359-62. PubMed ID: 16796504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia.
    Nytrøen K; Yardley M; Rolid K; Bjørkelund E; Karason K; Wigh JP; Dall CH; Arora S; Aakhus S; Lunde K; Solberg OG; Gustafsson F; Prescott EI; Gullestad L
    Am Heart J; 2016 Feb; 172():96-105. PubMed ID: 26856221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction and dependence to autonomy and freedom: transformation in adolescent heart transplant recipients.
    Adams J; Evangeli M; Lunnon-Wood T; Burch M
    Pediatr Transplant; 2014 Sep; 18(6):637-50. PubMed ID: 24923539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart transplant outcomes in recipients of Centers for Disease Control (CDC) high risk donors.
    Tsiouris A; Wilson L; Sekar RB; Mangi AA; Yun JJ
    J Card Surg; 2016 Dec; 31(12):772-777. PubMed ID: 27774722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool.
    Donoso Mantke O; Meyer R; Prösch S; Nitsche A; Leitmeyer K; Kallies R; Niedrig M
    J Heart Lung Transplant; 2005 Oct; 24(10):1632-8. PubMed ID: 16210141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
    Kataoka M; Margenthaler JA; Ku G; Eilers M; Flye MW
    Surgery; 2003 Aug; 134(2):227-34. PubMed ID: 12947322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart and heart-lung transplantation: standards and improvements.
    Harringer W; Haverich A
    World J Surg; 2002 Feb; 26(2):218-25. PubMed ID: 11865352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Regional Myocardial Mechanics in Transplanted Hearts: Influence of Time and Transplantation.
    Wengenmayer T; Stephan A; Grundmann S; Föll D; Beyersdorf F; Bode C; Geibel A
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):415-422. PubMed ID: 28030875
    [No Abstract]   [Full Text] [Related]  

  • 17. Heat shock protein 70 expression in native and heterotopically transplanted rat hearts.
    Mehta NK; Carroll M; Sykes DE; Tan Z; Bergsland J; Canty J; Bhayana JN; Hoover EL; Salerno TA
    J Surg Res; 1997 Jul; 70(2):151-5. PubMed ID: 9245564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Path From Heart Failure to Cardiac Transplant.
    Freeman R; Koerner E; Clark C; Halabicky K
    Crit Care Nurs Q; 2016; 39(3):207-13. PubMed ID: 27254637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Criteria for the acceptable heart donor: maximizing the use of hearts recovered from potential donors in Israel].
    Ben Gal T; Liel-Cohen N; Admon D; Freimark D; Lavee J; Elami A; Sahar G; Sagie A; Birk E; Cohen J; Ashkenazi T; Battler A
    Harefuah; 2007 Nov; 146(11):894-9, 908. PubMed ID: 18087839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial.
    Ardehali A; Esmailian F; Deng M; Soltesz E; Hsich E; Naka Y; Mancini D; Camacho M; Zucker M; Leprince P; Padera R; Kobashigawa J;
    Lancet; 2015 Jun; 385(9987):2577-84. PubMed ID: 25888086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.